中国每周两次血液透析：它能否成为起始或维持性透析治疗的更佳选择？
Twice-Weekly Hemodialysis in China: Can It Be A Better Option for Initiation or Maintenance Dialysis Therapy?
作者信息
Yan Yucheng, Ramirez Sylvia, Anand Shuchi, Qian Jiaqi, Zuo Li
机构信息
DaVita Hospital Management Consulting (Shanghai) Co.Ltd., Shanghai, China.
DaVita Healthcare Partners Inc, Singapore.
出版信息
Semin Dial. 2017 May;30(3):277-281. doi: 10.1111/sdi.12588. Epub 2017 Mar 26.
Abstract
Cumulative evidence indicates it may be worthwhile revisiting the twice-weekly hemodialysis (HD) regimen as a valid option for individualized or incremental treatments for selected patients with end-stage renal disease. In this article, we will review the current evidences on the potential pros and cons of twice-weekly HD compared to thrice-weekly HD including China's experience in the practice of twice-weekly HD. A prudent patient selection and close dialysis adequacy monitoring might be necessary for this medical treatment choice. More randomized prospective controlled studies for the critical evaluation of twice-weekly dialysis are encouraged.
摘要
越来越多的证据表明，对于某些终末期肾病患者，将每周两次的血液透析（HD）方案作为个体化或递增治疗的有效选择可能是值得的。在本文中，我们将回顾与每周三次HD相比，每周两次HD潜在利弊的现有证据，包括中国在每周两次HD实践中的经验。对于这种治疗选择，谨慎选择患者并密切监测透析充分性可能是必要的。鼓励开展更多随机前瞻性对照研究，以对每周两次透析进行批判性评估。
相似文献
1
Twice-Weekly Hemodialysis in China: Can It Be A Better Option for Initiation or Maintenance Dialysis Therapy?中国每周两次血液透析：它能否成为起始或维持性透析治疗的更佳选择？
Semin Dial. 2017 May;30(3):277-281. doi: 10.1111/sdi.12588. Epub 2017 Mar 26.
2
Twice-weekly and incremental hemodialysis treatment for initiation of kidney replacement therapy.两周三次和递增式血液透析治疗用于启动肾脏替代治疗。
Am J Kidney Dis. 2014 Aug;64(2):181-6. doi: 10.1053/j.ajkd.2014.04.019. Epub 2014 May 17.
3
Twice-Weekly Hemodialysis With Adjuvant Pharmacotherapy and Transition to Thrice-Weekly Hemodialysis: A Pilot Study.每周两次血液透析联合辅助药物治疗及过渡至每周三次血液透析：一项初步研究。
Am J Kidney Dis. 2022 Aug;80(2):227-240.e1. doi: 10.1053/j.ajkd.2021.12.001. Epub 2021 Dec 18.
4
Clinical outcome of twice-weekly hemodialysis patients in shanghai.上海地区每周两次血液透析患者的临床转归。
Blood Purif. 2012;33(1-3):66-72. doi: 10.1159/000334634. Epub 2011 Dec 29.
5
Comparison of outcomes between the incremental and thrice-weekly initiation of hemodialysis: a propensity-matched study of a prospective cohort in Korea.比较递增和每周三次起始血液透析的结局：韩国前瞻性队列的倾向评分匹配研究。
Nephrol Dial Transplant. 2017 Feb 1;32(2):355-363. doi: 10.1093/ndt/gfw332.
6
Once-weekly hemodialysis combined with low-protein and low-salt dietary treatment as a favorable therapeutic modality for selected patients with end-stage renal failure: a prospective observational study in Japanese patients.每周一次血液透析联合低蛋白低盐饮食治疗对选择的终末期肾衰竭患者是一种有利的治疗方式：日本患者的前瞻性观察研究。
BMC Nephrol. 2018 Jun 28;19(1):151. doi: 10.1186/s12882-018-0941-2.
7
Clinical Outcome of Twice-Weekly Hemodialysis Patients with Long-Term Dialysis Vintage.长期透析龄的每周两次血液透析患者的临床结局
Kidney Blood Press Res. 2018;43(4):1104-1112. doi: 10.1159/000491566. Epub 2018 Jul 10.
8
Infrequent dialysis: a new paradigm for hemodialysis initiation.非频繁透析：血液透析起始的新模式
Semin Dial. 2013 Nov-Dec;26(6):720-7. doi: 10.1111/sdi.12133. Epub 2013 Sep 9.
9
Nutritional status of twice and thrice-weekly hemodialysis patients with weekly Kt/V > 3.6.每周进行两次和三次血液透析且每周Kt/V>3.6的患者的营养状况
J Med Assoc Thai. 2009 May;92(5):624-31.
10
Association of initial twice-weekly hemodialysis treatment with preservation of residual kidney function in ESRD patients.初始每周两次血液透析治疗与终末期肾病患者残余肾功能保留的关联。
Am J Nephrol. 2014;40(2):140-50. doi: 10.1159/000365819. Epub 2014 Aug 23.
引用本文的文献
1
Risk Factors for Mortality Among Patients on Hemodialysis in India: A Case-Control Study.印度血液透析患者死亡的危险因素：一项病例对照研究。
Indian J Nephrol. 2025 May-Jun;35(3):390-396. doi: 10.25259/ijn_563_23. Epub 2024 Aug 8.
2
Twice against thrice-weekly hemodialysis (TATH): a multicenter nonrandomized trial.每周两次对比每周三次血液透析（TATH）：一项多中心非随机试验。
BMC Nephrol. 2025 Apr 5;26(1):176. doi: 10.1186/s12882-025-04105-3.
3
Hyperkalaemia prevalence and dialysis patterns in Chinese patients on haemodialysis: an interim analysis of a prospective cohort study (PRECEDE-K).血液透析患者高钾血症的患病率和透析模式：一项前瞻性队列研究（PRECEDE-K）的中期分析。
BMC Nephrol. 2023 Aug 9;24(1):233. doi: 10.1186/s12882-023-03261-8.
4
Incremental and Personalized Hemodialysis Start: A New Standard of Care.递增式和个性化血液透析起始治疗：一种新的护理标准
Kidney Int Rep. 2022 Feb 19;7(5):1049-1061. doi: 10.1016/j.ekir.2022.02.010. eCollection 2022 May.
5
Hyperkalaemia prevalence, recurrence and treatment in patients on haemodialysis in China: protocol for a prospective multicentre cohort study (PRECEDE-K).中国血液透析患者高钾血症的患病率、复发率和治疗：一项前瞻性多中心队列研究（PRECEDE-K）方案。
BMJ Open. 2021 Dec 22;11(12):e055770. doi: 10.1136/bmjopen-2021-055770.
6
Impact of twice- or three-times-weekly maintenance hemodialysis on patient outcomes: A multicenter randomized trial.每周两次或三次维持性血液透析对患者预后的影响：一项多中心随机试验。
Medicine (Baltimore). 2020 May;99(20):e20202. doi: 10.1097/MD.0000000000020202.
7
Intradialytic complications among patients on twice-weekly maintenance hemodialysis: an experience from a hemodialysis center in Eritrea.厄立特里亚某血液透析中心每周两次维持性血液透析患者的透析中并发症：一项经验研究。
BMC Nephrol. 2020 May 5;21(1):163. doi: 10.1186/s12882-020-01806-9.
8
Prescribing Hemodialysis or Hemodiafiltration: When One Size Does Not Fit All the Proposal of a Personalized Approach Based on Comorbidity and Nutritional Status.开具血液透析或血液滤过治疗处方：当一种方案并不适用于所有人时——基于合并症和营养状况的个性化方法建议
J Clin Med. 2018 Oct 8;7(10):331. doi: 10.3390/jcm7100331.
9
The strange case of Mr. H. Starting dialysis at 90 years of age: clinical choices impact on ethical decisions.H先生的奇特案例：90岁开始透析——临床选择对伦理决策的影响
BMC Med Ethics. 2017 Nov 9;18(1):61. doi: 10.1186/s12910-017-0219-4.
本文引用的文献
1
Anemia Management in the China Dialysis Outcomes and Practice Patterns Study.中国透析结局和实践模式研究中的贫血管理
Blood Purif. 2016;42(1):33-43. doi: 10.1159/000442741. Epub 2016 Mar 31.
2
Comparison of Outcomes with Arteriovenous Fistula and Arteriovenous Graft for Vascular Access in Hemodialysis: A Prospective Cohort Study.动静脉内瘘与动静脉移植物用于血液透析血管通路的结局比较：一项前瞻性队列研究
Am J Nephrol. 2016;43(2):120-8. doi: 10.1159/000444889. Epub 2016 Mar 30.
3
Comparison of Clinical Outcome Between Twice-Weekly and Thrice-Weekly Hemodialysis in Patients With Residual Kidney Function.残余肾功能患者每周两次与每周三次血液透析的临床结局比较
Medicine (Baltimore). 2016 Feb;95(7):e2767. doi: 10.1097/MD.0000000000002767.
4
Incremental Hemodialysis, Residual Kidney Function, and Mortality Risk in Incident Dialysis Patients: A Cohort Study.新透析患者的递增式血液透析、残余肾功能与死亡风险：一项队列研究
Am J Kidney Dis. 2016 Aug;68(2):256-265. doi: 10.1053/j.ajkd.2016.01.008. Epub 2016 Feb 9.
5
Adequacy of twice weekly hemodialysis in end stage renal disease patients at a tertiary care dialysis centre.三级医疗透析中心终末期肾病患者每周两次血液透析的充分性
Indian J Nephrol. 2015 Nov-Dec;25(6):329-33. doi: 10.4103/0971-4065.151762.
6
What Is Known and Unknown About Twice-Weekly Hemodialysis.关于每周两次血液透析的已知与未知情况
Blood Purif. 2015;40(4):298-305. doi: 10.1159/000441577. Epub 2015 Nov 17.
7
KDOQI Clinical Practice Guideline for Hemodialysis Adequacy: 2015 update.KDOQI 临床实践指南：血液透析充分性 2015 年更新版。
Am J Kidney Dis. 2015 Nov;66(5):884-930. doi: 10.1053/j.ajkd.2015.07.015.
8
Dialysis dose and risk factors for death among ESRD patients treated with twice-weekly hemodialysis: a prospective cohort study.每周两次血液透析治疗的终末期肾病患者的透析剂量与死亡风险因素：一项前瞻性队列研究。
Blood Purif. 2014;38(3-4):253-62. doi: 10.1159/000368885. Epub 2015 Jan 6.
9
The incremental treatment of ESRD: a low-protein diet combined with weekly hemodialysis may be beneficial for selected patients.终末期肾病的增量治疗：低蛋白饮食联合每周一次的血液透析可能对部分患者有益。
BMC Nephrol. 2014 Oct 29;15:172. doi: 10.1186/1471-2369-15-172.
10
Association of initial twice-weekly hemodialysis treatment with preservation of residual kidney function in ESRD patients.初始每周两次血液透析治疗与终末期肾病患者残余肾功能保留的关联。
Am J Nephrol. 2014;40(2):140-50. doi: 10.1159/000365819. Epub 2014 Aug 23.
Zotero 插件